Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soff

Showing results (151-160 of 202) with videos related to

Pageof 21
Sort By:
Cancer Research|July 23, 2003
Angiostatin(4.5)-mediated apoptosis of vascular endothelial cellsHolly Anne Hanford, Christie A Wong, Hallie Kassan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
In vivo generation of angiostatin isoforms by administration of a plasminogen activator and a free sulfhydryl donor: a phase I study of an angiostatic cocktail of tissue plasminogen activator and mesnaGerald A Soff, Hao Wang, Deborah L Cundiff, et al.
Journal of Medicinal Chemistry|May 13, 2005
N-methylsansalvamide a peptide analogues. Potent new antitumor agentsShouxin Liu, Wenxin Gu, Denise Lo, et al.
The American Journal of Cardiology|May 28, 2017
Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active CancerEva S Laube, Anthony Yu, Dipti Gupta, et al.
Cancer Research|July 20, 2006
Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesisHao Wang, Jennifer A Doll, Keyi Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysisRussell A Moore, Nelly Adel, Elyn Riedel, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2024
Developing an instrument to measure the quality of social work cancer counseling regarding return to work - psychometric properties of the German Quality of Cancer Counseling Questionnaire-Return to Work (QCCQ-W)Clara Breidenbach, Sabine Schneider, Marie Rösler, et al.
Cancers|January 28, 2026
Romiplostim for Prevention of Severe Chemotherapy-Induced Thrombocytopenia in Lymphoma Patients-Phase I StudyErel Joffe, Zachary Epstein-Peterson, Lorenzo Falchi, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|May 29, 2020
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI TrialAlok A Khorana, Mairéad G McNamara, Ajay K Kakkar, et al.
Cancer|October 13, 2011
Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancerAndrew S Epstein, Gerald A Soff, Marinela Capanu, et al.
Pageof 21

Showing results (151-160 of 202) with videos related to

Sort By:
Pageof 21
Cancer Research|July 23, 2003
Angiostatin(4.5)-mediated apoptosis of vascular endothelial cellsHolly Anne Hanford, Christie A Wong, Hallie Kassan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
In vivo generation of angiostatin isoforms by administration of a plasminogen activator and a free sulfhydryl donor: a phase I study of an angiostatic cocktail of tissue plasminogen activator and mesnaGerald A Soff, Hao Wang, Deborah L Cundiff, et al.
Journal of Medicinal Chemistry|May 13, 2005
N-methylsansalvamide a peptide analogues. Potent new antitumor agentsShouxin Liu, Wenxin Gu, Denise Lo, et al.
The American Journal of Cardiology|May 28, 2017
Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active CancerEva S Laube, Anthony Yu, Dipti Gupta, et al.
Cancer Research|July 20, 2006
Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesisHao Wang, Jennifer A Doll, Keyi Jiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysisRussell A Moore, Nelly Adel, Elyn Riedel, et al.
Journal of Cancer Research and Clinical Oncology|December 5, 2024
Developing an instrument to measure the quality of social work cancer counseling regarding return to work - psychometric properties of the German Quality of Cancer Counseling Questionnaire-Return to Work (QCCQ-W)Clara Breidenbach, Sabine Schneider, Marie Rösler, et al.
Cancers|January 28, 2026
Romiplostim for Prevention of Severe Chemotherapy-Induced Thrombocytopenia in Lymphoma Patients-Phase I StudyErel Joffe, Zachary Epstein-Peterson, Lorenzo Falchi, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|May 29, 2020
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI TrialAlok A Khorana, Mairéad G McNamara, Ajay K Kakkar, et al.
Cancer|October 13, 2011
Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancerAndrew S Epstein, Gerald A Soff, Marinela Capanu, et al.
Pageof 21